Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
Clinical trial NCT00268684 · UNKNOWN
Trial details
- NCT number
- NCT00268684
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.